ArticleDigital health
A unified VQ-VAE framework for few-shot retinal vessel segmentation and multidisease classification.
Article in Digital health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To address the reliance of task-specific deep learning models on large annotated datasets, this study investigates a Vector Quantized Variational Autoencoder (VQ-VAE) based few-shot learning framework for retinal vessel segmentation and disease classification. Methods: A compact VQ-VAE was pretrained on unlabeled fundus photographs to learn transferable discrete representations. The pretrained encoder was used to initialize multiple downstream models, including segmentation networks (U-Net, SegNet, ERFNet) and three additional architectures (FR-UNet, Swin-Res-Net, RV-GAN), as well as classification networks (VGG-16, ResNet-50, EfficientNet-B0). Retinal vessel segmentation was evaluated on three public datasets (DRIVE, STructured Analysis of the Retina [STARE], and CHASE), while disease classification was assessed on the Retina and Ocular Disease Intelligent Recognition (ODIR) datasets. Segmentation performance was evaluated using Dice coefficient, Recall, Accuracy, Intersection over Union (IoU), mean IoU, and Average Offset Distance. Classification performance was assessed using accuracy, precision, recall, F1-score, and area under the receiver operating characteristic curve (AUC), with additional validation on the heterogeneous ODIR dataset. Results: The VQ-VAE pretraining consistently improved performance under small-sample conditions. On the DRIVE dataset, Dice scores increased by approximately 2 percentage points across all segmentation backbones, with U-Net improving from 0.780 to 0.796 and SegNet from 0.670 to 0.692. Consistent performance improvements were also observed on the STARE and CHASE datasets. For disease classification on the Retina dataset, accuracy increased from 20% to 60% using only 70 labeled images. On the ODIR dataset, mean AUC improved across architectures, from 0.677 to 0.724 for VGG-16, 0.684 to 0.745 for ResNet-50, and 0.664 to 0.726 for EfficientNet-B0, indicating enhanced robustness across diverse disease categories and imaging conditions. Conclusion: The proposed pretraining framework effectively reduces labeled data requirements while improving performance across multiple ophthalmic tasks, offering a scalable and resource-efficient solution for real-world clinical applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.